🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Two independent study parts (i.e. Part A and Part B) are included in this t...
Status
Completed
Location
Tokai Memorial Hospital
Start Date
2015-05-12
Trial ID
NCT02489968
The primary objective of the current study is to investigate the relative b...
Status
Completed
Location
1275.3.1 Boehringer Ingelheim Investigational Site
Start Date
2010-08
Trial ID
NCT01189201
Treatments Being Tested
This trial will evaluate use of BI 10773/linagliptin once daily (qd) fixed ...
Status
Completed
Location
1275.1.01103 Boehringer Ingelheim Investigational Site
Start Date
2011-08
Trial ID
NCT01422876
Treatments Being Tested
To establish the bioequivalence of one fixed dose combination (FDC) tablet ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-08-31
Trial ID
NCT03259490
Treatments Being Tested
This trial compare the use of two different doses of Empagliflozin to place...
Status
Completed
Location
1275.9.01013 Boehringer Ingelheim Investigational Site
Start Date
2013-02-08
Trial ID
NCT01734785
The purpose of this trial is to demonstrate the relative bioavailability of...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2016-07-20
Trial ID
NCT02821910
Treatments Being Tested
This trial will compare the use of fixed dose combination of empagliflozin ...
Status
Completed
Location
Nagoya Kyoritsu Hospital
Start Date
2015-05-14
Trial ID
NCT02453555